Johannes Eduard Delport1, Khanyisa Makamba2. 1. Medical Officer, Department of Urology, Port Elizabeth Provincial Hospital, Buckingham Road, Mount Croix, Port Elizabeth, Eastern Cape South Africa. 2. Head of Clinical Unit, Department of Urology, Port Elizabeth Provincial Hospital, Buckingham Road, Mount Croix, Port Elizabeth, Eastern Cape South Africa.
Abstract
BACKGROUND: Bladder cancer is the 17th most common cancer in the female population. Most bladder cancers are of urothelial origin. Sarcomas of the bladder are very uncommon. CASE PRESENTATION: This case concerns a 57-year-old female from a rural town in the Eastern Cape who was diagnosed with myxoid/round cell liposarcoma of the bladder. After the initial transurethral resection of the bladder tumour, she underwent an anterior exenteration with Bricker's diversion (ileal conduit) and negative margins were achieved. CONCLUSIONS: Sarcomas of the bladder are known to have a poor prognosis. Our patient is alive with good stoma function more than 24 months since her radical surgery. We are of the opinion that her favourable overall survival is attributable to early radical surgical intervention with negative margins.
BACKGROUND: Bladder cancer is the 17th most common cancer in the female population. Most bladder cancers are of urothelial origin. Sarcomas of the bladder are very uncommon. CASE PRESENTATION: This case concerns a 57-year-old female from a rural town in the Eastern Cape who was diagnosed with myxoid/round cell liposarcoma of the bladder. After the initial transurethral resection of the bladder tumour, she underwent an anterior exenteration with Bricker's diversion (ileal conduit) and negative margins were achieved. CONCLUSIONS: Sarcomas of the bladder are known to have a poor prognosis. Our patient is alive with good stoma function more than 24 months since her radical surgery. We are of the opinion that her favourable overall survival is attributable to early radical surgical intervention with negative margins.
Authors: N Mondaini; D Palli; C Saieva; G Nesi; A Franchi; R Ponchietti; S Tripodi; C Miracco; E Meliani; M Carini; L Livi; I Zanna; S Trovarelli; V Marino; G Vignolini; G Pomara; V Orlando; G Giubilei; C Selli; M Rizzo Journal: Eur Urol Date: 2004-11-10 Impact factor: 20.096
Authors: Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan Journal: Eur Urol Date: 2012-07-25 Impact factor: 20.096
Authors: M Veiga González; M F Fresno Forcelledo; M J Pérez del Río; B Madrigal Rosales; A Vara Gastrodeza; A Herrero Zapatero Journal: Arch Esp Urol Date: 1998-11 Impact factor: 0.436
Authors: Federica Grosso; Robin L Jones; George D Demetri; Ian R Judson; Jean-Yves Blay; Axel Le Cesne; Roberta Sanfilippo; Paola Casieri; Paola Collini; Palma Dileo; Carlo Spreafico; Silvia Stacchiotti; Elena Tamborini; Juan Carlos Tercero; Josè Jimeno; Maurizio D'Incalci; Alessandro Gronchi; Jonathan A Fletcher; Silvana Pilotti; Paolo G Casali Journal: Lancet Oncol Date: 2007-07 Impact factor: 41.316